93434 ⎘
Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups; Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
LPXH TARGETING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF MAKING AND USING THE SAME
#2COMPOSITIONS AND METHODS RELATED TO BICYCLO[2.2.1] HEPTANAMINE-CONTAINING COMPOUNDS
#3NAMPT MODULATORS
#4OPIOID RECEPTOR AGONIST, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF
#5Ferroptosis inducing compound, compositions comprising the same, and methods of inducing ferroptosis
#6Peripheral alkyl and alkenyl chains extended benzene derivatives and pharmaceutical composition including the same
#7SULFAMOYL-ARYLAMIDES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B
#8PENTAFLUOROPHENYL SULFONAMIDE COMPOUNDS, COMPOSITIONS AND USES THEREOF
#9SULFAMOYL-ARYLAMIDES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B
#10Method for producing optically active substance, optically active substance, method for producing chiral molecule, and chiral molecule
#11Sulfonamides as GPR40- and GPR120-agonists
#12Fluorinated cyclopropylamine compound, preparation method therefor, pharmaceutical composition thereof, and uses thereof
#13N-(4-hydroxy-4-methyl-cyclohexyl)-4-phenyl-benzenesulfonamides and N-(4-hydroxy-4-methyl-cyclohexyl)-4-(2-pyridyl)benzenesulfonamides and their therapeutic use
#14N-(4-HYDROXY-4-METHYL-CYCLOHEXYL)-4-PHENYL-BENZENESULFONAMIDE AND N-(4-HYDROXY-4-METHYL-CYCLOHEXYL)-4-(2-PYRIDYL)-BENZENESULFONAMIDE COMPOUNDS AND THEIR THERAPEUTIC USE
#15Process for hydrogenating ketones in the presence of Ru(II) catalysts
#16SMALL MOLECULES FOR THE MODULATION OF MCL-1 AND METHODS OF MODULATING CELL DEATH, CELL DIVISION, CELL DIFFERENTIATION AND METHODS OF TREATING DISORDERS
#17NOVEL ANTIVIRAL AGENTS AGAINST HBV INFECTION
#18ROR gamma (RORγ) modulators
#19ROR gamma (RORγ) modulators
#20Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B
#21Method of inhibiting apolipoprotein-E expression while increasing expression of at least one of LDL-receptor protein or AbcA1 protein comprising administering a small compound
#22N-(4-hydroxy-4-methyl-cyclohexyl)-4-phenyl-benzenesulfonamides and N-(4-hydroxy-4-methyl-cyclohexyl)-4-(2-pyridyl)benzenesulfonamides and their therapeutic use
#23N-(4-hydroxy-4-methyl-cyclohexyl)-4-phenyl-benzenesulfonamide and N-(4-hydroxy-4-methyl-cyclohexyl)-4-(2-pyridyl)-benzenesulfonamide compounds and their therapeutic use
#24FLT3 receptor antagonists
#25N-(4-hydroxy-4-methyl-cyclohexyl)-4-phenyl-benzenesulfonamides and N-(4-hydroxy-4-methyl-cyclohexyl)-4-(2-pyridyl)benzenesulfonamides and their therapeutic use
#26Dicarboxylic acid compound
#27ROR gamma (RORγ) modulators
#28Aryl-phenyl-sulfonamido-cycloalkyl compounds and their use
#29N-(4-hydroxy-4-methyl-cyclohexyl)-4-phenyl-benzenesulfonamides and N-(4-hydroxy-4-methyl-cyclohexyl)-4-(2-pyridyl)benzenesulfonamides and their therapeutic use
#30Dicarboxylic acid compound
#31Cycloalkyl-dione derivatives and methods of their use
#32Sulfonamide TRPA1 receptor antagonists
#33Antiviral agents against HBV infection
#34Small molecules for the modulation of MCL-1 and methods of modulating cell death, cell division, cell differentiation and methods of treating disorders
#35Derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine and uses thereof
#36Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B
#37Aryl-phenyl-sulfonamido-cycloalkyl compounds and their use
#38Use of a Compound for Inducing Differentiation of Mesenchymal Stem Cells into Cartilage Cells
#39Substituted sulfonamide compounds
#40Bicyclic compound
#41Pharmaceutical composition with enhanced efficacy for inhibiting angiogenesis
#42Cannabinoid receptor 2 (CB2) inverse agonists and therapeutic potential for multiple myeloma and osteoporosis bone diseases
#43Novel Sulfonamides
#44Small molecule inhibitors of Mcl-1 and the uses of thereof
#45Tricyclic compounds as anticancer agents
#46Compound for inhibiting 11β-hydroxy steroid dehydrogenase 1, and a pharmaceutical composition comprising the same
#47Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
#48Aryl-phenyl-sulfonamido-cycloalkyl compounds and their use
#49Use of compounds for inducing differentiation of mesenchymal stem cells to chondrocytes
#50Substituted naphthylacetic acids
#51Novel Tetrahydronaphalene Antagonists to the Thromboxane A2 (TP) Receptor
#52Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
#53Cannabinoid receptor 2 (CB2) inverse agonists and therapeutic potential for multiple myeloma and osteoporosis bone diseases
#54Thromboxane A2 (TP) receptor antagonists
#55SMALL MOLECULES FOR THE MODULATION OF MCL-1 AND METHODS OF MODULATING CELL DEATH, CELL DIVISION, CELL DIFFERENTIATION AND METHODS OF TREATING DISORDERS
#56ORGANIC COMPOUNDS
#57Cross-coupled peptide nucleic acids for detection of nucleic acids of pathogens
#58BENZOCYCLOHEPTENE ACETIC ACIDS
#59N-substituted benzene sulfonamides
#60Derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine and uses thereof
#61Process for hydrogenating ketones in the presence of Ru(II) catalysts
#62Cross-Coupled Peptide Nucleic Acids for Detection of Nucleic Acids of Pathogens
#63Compositions and methods for the treatment of disease associated with TRP-P8 expression
#64N-hydroxy-benzamids for the treatment of cancer
#65SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF
#66Compounds that inhibit (block) bitter taste in composition and methods of making same
#67Proteasome inhibitors for selectively inducing apoptosis in cancer cells
#68Aryl-phenyl-sulfonamido-cycloalkyl compounds and their use
#69Cyclohexane derivatives and uses thereof
#70NPY Y5 ANTAGONIST
#71Probes, Systems, and Methods for Drug Discovery
#72Long-chain fatty acyl elongase inhibitor comprising arylsulfonyl derivative as active ingredient
#73CHEMICAL COMPOUNDS
#74ANTAGONISTS OF PGD2 RECEPTORS
#75NPY Y5 antagonist
#76Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
#77Amine derivative having NPY Y5 receptor antagonistic activity
#78Derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine and uses thereof
#79Substituted Phenylsulfonamide Inhibitors of Beta Amyloid Production
#80SYNTHESIS OF TRANS-TERT-BUTYL-2-AMINOCYCLOPENTYLCARBAMATE
#81Method for producing optically active aziridine compounds and amine compounds as well as complexes and their intermediates used in this method
#82Method for producing optically active aziridine compounds and amine compounds as well as complexes and their intermediates used in this method
#83Cyclopropane compounds and pharmaceutical use thereof
#84Amine derivative having NPY Y5 receptor antagonistic activity
#85Selective TR-β 1 agonist
#86MONOARYL AMINOTETRALINES
#87Bi-aryl aminotetralines
#88Substituted aminotetralines
#89Substituted cyclohexylmethyl compounds
#90Compounds that inhibit (block) bitter taste in composition and use thereof
#91Non-Peptidic Inhibitors of AKAP/PKA Interaction
#92TRICYCLIC STEROID HORMONE NUCLEAR RECEPTOR MODULATORS
#93Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
#94SOLUBLE EPOXIDE HYDROLASE INHIBITORS
#95Association between an anti-atherothrombotic and an angiotensin-converting enzyme inhibitor
#9611-Beta-Hydroxysteroid Dehydrogenase Inhibitors
#97α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
#98Nonpeptide inhibitors of matrix metalloproteinases
#99Cyclopropane compounds and pharmaceutical use thereof
#100Substituted amide compounds
#101Novel compounds and a novel process for their preparation
#102CYCLOPROPANE COMPOUNDS AND PHARMACEUTICAL USE THEREOF
#103N-Substituted-N-Sulfonylaminocyclopropane Compounds and Pharmaceutical Use Thereof
#104Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors
#105Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
#106Method for producing optically active aziridine compounds and amine compounds as well as complexes and their intermediates used in this method
#107N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
#108Sulfonylamino-acetic acid derivatives
#109N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives
#110Process for the preparation of CCR-2 antagonists
#111Tetrahydronaphthalene derivatives, processes for their preparation and their use as antiinflammatory agents
#112Resorcinol derivatives
#113α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
#1142-Cyanobenzenesulfonamides for combating animal pests
#115Substituted phenylsulfonamide inhibitors of beta amyloid production
#116NPY Y5 antagonist
#117Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors
#118Sulfonamides as potassium channel blockers
#119α- and β-Amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
#120Cyclopropane compounds and pharmaceutical use thereof
#121Hexafluoroisopropanol substituted cyclohexane derivatives
#122Sulfonamides as potassium channel blockers
#123Tricyclic steroid hormone nuclear receptor modulators
#124Pharmaceutically useful compounds
#125Sulfonylamino-acetic acid derivatives
#126Resorcinol derivatives
#127ABCA-1 elevating compounds
#128α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
#129N-substituted benzene sulfonamides
#130N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
#131Diamines having a CaSR modulating activity
#1322,3-Oxidosqualene-lanosterol cyclase inhibitors
#133Method for labeling with tritium
#134Antiamyloid phenylsulfonamides: N-cycloalkylcarboxamides derivatives
#135Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors
#136Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors
#1375-HTreceptor antagonists
#138Aminoalkylamide substituted cyclohexyl derivatives
#139Compositions and methods for the treatment of disease associated with Trp-p8 expression
#140Compounds and a novel process for their preparation
#141Hydroxyalkylamide derivatives
#142N-phenyl and N-benzyl enaminones and methods for using same